Lifecore Biomedical, Inc. Common Stock LFCR

$6.52 +55.24% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-29 View →
8-K 8-K 2026-09-28 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
8-K 8-K 2026-07-02 View →
4 OWNERSHIP DOCUMENT 2026-06-08 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
4 FORM 4 2026-06-05 View →
8-K 8-K 2026-06-05 View →
4 FORM 4 2026-05-21 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
DEF 14A DEF 14A 2026-04-24 View →
4 FORM 4 2026-04-16 View →
8-K 8-K 2026-03-16 View →
8-K 8-K 2026-03-05 View →
4 FORM 4 2026-03-02 View →
8-K 8-K 2026-01-16 View →
8-K 8-K 2025-11-17 View →
10-Q 10-Q 2025-11-06 View →
8-K 8-K 2025-11-06 View →
8-K 8-K 2025-10-31 View →
8-K 8-K 2025-09-26 View →
S-3 S-3 2025-09-23 View →
DEF 14A DEF 14A 2025-09-18 View →
4 FORM 4 2025-09-04 View →
8-K 8-K 2025-08-18 View →
8-K 8-K 2025-08-12 View →
10-K 10-K 2025-08-07 View →
8-K 8-K 2025-08-07 View →
8-K 8-K 2025-07-18 View →
4 FORM 4 2025-07-17 View →
4 OWNERSHIP DOCUMENT 2025-07-17 View →
4 FORM 4 2025-07-17 View →
4 FORM 4 2025-07-17 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$6.52
Market Cap
$158.98 million
52-Week Range
$3.63 – $8.98
Average Volume
268K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.